SciELO - Scientific Electronic Library Online

 
vol.33 número1Linfomas Gastrointestinales de Inmunofenotipo B asociados a Enfermedad celíaca, Helicobacter pylori y Virus de Epstein Barr.: Aspectos clínicopatológicos y análisis inmunomolecularNiveles de atención, de prevención y atención primaria de la salud índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Archivos de Medicina Interna

versión impresa ISSN 0250-3816versión On-line ISSN 1688-423X

Resumen

SEVRINI, Inés et al. Prospective Trial on Thrombophilia and Pregnancy at the Clinicas Hospital: April 2004 - February 2010. Arch. Med Int [online]. 2011, vol.33, n.1, pp.6-10. ISSN 0250-3816.

Background: The physiological hypercoagulable state of pregnancy associated with thrombophilia can not only determine thromboembolic disease but may interfere with placental circulation causing obstetric events be linked to thrombophilia (MOV): recurrent pregnancy loss, premature separation of placenta, intrauterine fetal growth restriction, the stillbirth and preeclampsia. Treatment with low molecular weight heparins has changed the course of pregnancy in these patients. The objective of this program is to determine the prevalence of thrombophilia in the population of pregnant women with suspected thrombophilia and achieve healthy newborns. Methods: Patients with thrombophilia or high suspicion of thrombophilia by their personal history of thrombosis or obstetric history be linked with thrombophilia. Etiological studies were performed for acquired and congenital thrombophilia and prescribed a treatment and as a personal follow up and treatment protocol preset. Results: Of a total of 207 patients who completed the pregnancy, thrombophilia was confirmed in 63.3% of patients. It was possible to obtain healthy live births and in 81.3% of patients, only by 9.7% were abortions or stillbirths. Conclusion: With strict clinical and laboratory controls and settings according to the etiology and treatment monitoring, we obtained high percentage of healthy newborns and in patients with thrombophilia or MOV.

Palabras clave : thrombophilia; pregnancy; recurrent pregnancy loss.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons